CAR-M1 Macrophage - It is Gene-Therapy for solid tumors and effective for treating solid tumor. This technology provides cost efficient off-the-shelf gene therapy, triggers innate and adaptive immunity. In addtion, it is less likely to cause toxic side effects. - Nanocomplexes comprising macrophage-targeting nanocarriers and CAR-interferon-γ-ncoding plasmid DNA induce mac ...View more

Unmet Needs• Nonalcoholic steatohepatitis (NASH) is a liver disease that is characterized by the accumulation of fat in the liver, inflammation, and liver cell damage with multiple underlying factors contributing to its pathogenesis such as obesity, insulin resistance, dyslipidemia, and gut dysbiosis• There are currently no FDA-approved drugs for the treatment of NA ...View more